Turkmenistan Medical Device Registration: National Format Dossier Requirements

1. Key takeaways

The registration dossier in Turkmenistan is subject to three hard format requirements, and all three operate simultaneously rather than as alternatives:

• Format: the dossier must be compiled in the national format, following the approved document list;
• Medium: submission is on paper;
• Number of sets: two sets are required, namely the original and one identical copy, bound and filed separately.

CTD or other formats are not unusable, but prior consent from the competent authority must be obtained. This exception channel matters for multinational manufacturers who already maintain complete CTD dossiers, yet it is conditioned on an approval step that must be completed before submission, and it cannot be cured retroactively once a national-format file has been filed or a CTD file has been lodged without consent. Companies should decide their format strategy early, because the choice determines how much re-editing work sits between the existing document set and a submissible Turkmenistan dossier.

2. Legal basis

The documentation requirements in Law No. 319-V of January 12, 2016 establish the general obligation to submit a registration dossier, while the Regulation on National Registration of Medicines and Medical Devices approved by the Ministry of Health specifies the national format, the paper medium, the two-set requirement, and the conditions under which the CTD or another format may be accepted with prior consent. Because the Regulation carries no public number, applicants should confirm the current text through the competent authority or their local representative.

3. Expert insights

Insight 1: the national format means CTD or Chinese registration files cannot be reused as they stand.

Turkmenistan requires a dossier in its own national format, whose section structure is dictated by the approved document list. The NMPA registration files familiar to Chinese companies, as well as the structure of European Union technical documentation, both need to be rearranged. This is the single largest block of workload in the preparation phase. The rearrangement is not cosmetic: the approved list determines which documents exist, in which order, and under which headings, so mapping the existing evidence onto the national structure is a project in its own right, with its own owner, timeline and quality review.

Insight 2: two paper sets are the current reality, in contrast with digital government services.

The dossier must be submitted on paper in two sets; at the same time, the website of the Ministry of Health has launched digital service sections and is connected to the national e-government portal (article 47). This contrast tells us that digital services and paper requirements may coexist for a long time, and that paper is the current submission requirement. Companies should not extrapolate from the existence of digital portals that an electronic submission channel is available for registration dossiers, and should budget for printing, binding and physical logistics as real project tasks with real lead times.

Insight 3: the identical copy is not as simple as a photocopy.

The regulatory wording refers to the original and the identical copy, and requires that they be bound and filed separately. The practical meaning is that the copy must be fully identical to the original, including the arrangement of signature pages and annexes. Attempting to satisfy the requirement with an original plus scanned printouts is easily picked up during the completeness check of the preliminary review, and a discrepancy between the two sets can send the file back before any technical assessment begins. Treat the copy set as a controlled reproduction of the original, verified page by page.

Insight 4: CTD requires prior consent, which is a clearly defined exception channel.

The dossier may be submitted in CTD or another format, but prior approval from the competent authority is required. For companies that already hold complete CTD documentation, this is a path that can save substantial re-editing work, but written consent must be obtained before submission; there is no after-the-fact remedy. The consent request itself takes time and should be raised through the local representative as soon as the format decision is made, so that the answer arrives before dossier compilation is finalized either way.

Insight 5: certain documents must be originals or legalized copies.

The regulatory wording specifically provides that documents such as the power of attorney (POA), the GMP certificate, the CPP and/or registration certificates issued in the country of manufacture and in other countries must be submitted as originals or legalized copies. This connects directly to the consular legalization chain described in article 15. These documents therefore carry not only content requirements but also authentication requirements, and their acquisition timelines should be planned jointly with the legalization schedule rather than treated as ordinary dossier attachments.

4. Practical recommendations

1. Recompile the dossier in the Turkmenistan national format, and do not apply CTD or NMPA structures directly without mapping them onto the approved document list.
2. Bind the two paper sets separately, and verify that the copy matches the original page by page, including signatures and annex order.
3. If CTD is intended, obtain the written consent of the competent authority before submission.
4. Prepare the POA, GMP, CPP and country-of-origin registration certificates as originals or legalized copies.
5. Build a page-level index of the dossier, which supports the completeness check of the preliminary review and the rapid location of documents in later queries.

5. Verification checklist

• □ The dossier has been recompiled in the national format.
• □ Two paper sets (original + identical copy) have been prepared and bound separately.
• □ Where CTD is intended, written consent of the competent authority has been obtained.
• □ The POA, GMP, CPP and country-of-origin registration certificates have been prepared as originals or legalized copies.
• □ A page-level index of the dossier has been established.

Regulatory information verified as of October 30, 2026. The content of this document was checked against Law No. 319-V on the Supply of Medicines (January 12, 2016) and the Regulation on National Registration of Medicines and Medical Devices approved by the Ministry of Health; the requirements for the national format, two paper sets, and prior consent for CTD come from the consistent description of the current Regulation, and the specific section structure follows the current Regulation.

• Local resources in Turkmenistan: GRZAN can coordinate licensed local import entities and authorized representative resources, covering national registration submission, the consular legalization chain for documents, sample delivery, interfaces with mandatory TDS certification, and customs clearance support.
• Service scope: classification determination, selection of the registration pathway, preparation of national-format dossiers, consular legalization and notarization, preparation of testing and stability documentation, organization of GMP and ISO 13485 evidence, changes and renewal, vigilance and post-market maintenance.
• Contact: GRZAN supports manufacturers, importers and authorized representatives with registration in this country; reach us at info@grzanglobal.com.